← Back to Clinical Trials
Recruiting NCT05329714

NCT05329714 PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05329714
Status Recruiting
Phase
Sponsor University of Giessen
Condition Pulmonary Hypertension
Study Type OBSERVATIONAL
Enrollment 40,000 participants
Start Date 2020-01-30
Primary Completion 2050-01-30

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40,000 participants in total. It began in 2020-01-30 with a primary completion date of 2050-01-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

PVRI-GoDeep is a PH Meta-Registry, run under the umbrella of the Pulmonary Vascular Research Institute (PVRI). It merges anonymized PH patient related data from various local registries around the world run under the responsibility of PVRI members. It will be operated under the auspices of the University of Giessen/Giessen PH center. Combining deep phenotyping with worldwide outreach, PVRI-GoDeep aims to offer insights into specific geographical and ethnical profiles of PH, to deepen the epidemiological, clinical and molecular understanding of this disease and to promote strategies for improved individualized treatment of PH patients.

Eligibility Criteria

Inclusion Criteria: * Clinical Diagnosis of Pulmonary Hypertension Exclusion Criteria: * none

Contact & Investigator

Central Contact

Raphael W Majeed

✉ raphael.majeed@innere.med.uni-giessen.de

📞 +49 641 985 42502

Frequently Asked Questions

Who can join the NCT05329714 clinical trial?

This trial is open to participants of all sexes, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05329714 currently recruiting?

Yes, NCT05329714 is actively recruiting participants. Contact the research team at raphael.majeed@innere.med.uni-giessen.de for enrollment information.

Where is the NCT05329714 trial being conducted?

This trial is being conducted at Giessen, Germany.

Who is sponsoring the NCT05329714 clinical trial?

NCT05329714 is sponsored by University of Giessen. The trial plans to enroll 40,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology